Salmenkylä, Tellu
Kilpivaara, Katariina
Ohtonen, Pasi
Rautio, Tero
Mäkäräinen, Elisa
Article History
Received: 25 March 2022
Accepted: 22 July 2022
First Online: 30 July 2022
Declarations
:
: This study was approved by The Ethical Committee of the Northern Finland Hospital District, Oulu, Finland (Reference 266/2018). The study was conducted in accordance with the ethical standards of the institutional and/or national research committee and with the Helsinki Declaration of 1964, as revised in 2013. All treatment subjects gave their informed consent prior to enrollment. As the control group was registry-based, no additional consent to participate was needed. The patients are not identifiable.
: Not applicable.
: EM reports consultancy fees by Medtronic. All other authors confirm they have no disclosures.